| Dr Alyssa Songveera, MD | |
|
1 Medical Center Blvd, Chester, PA 19013-3902 | |
| (610) 447-6680 | |
| Not Available |
| Full Name | Dr Alyssa Songveera |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1 Medical Center Blvd, Chester, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619537800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MT219245 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alyssa Songveera, MD 1 Medical Center Blvd, Upland, PA 19013 Ph: (610) 447-6680 | Dr Alyssa Songveera, MD 1 Medical Center Blvd, Chester, PA 19013-3902 Ph: (610) 447-6680 |
News Archive
Meta-analysis findings question whether beta-blocker treatment remains effective in patients who have heart failure with reduced left ventricular ejection fraction if they also have atrial fibrillation.
Janssen-Cilag International NV has announced the submission of a Type II variation application to the European Medicines Agency (EMA), seeking to broaden the existing marketing authorisation for the immunotherapy DARZALEX® (daratumumab) to include treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy. The expanded indication is based on daratumumab in combination with lenalidomide (an immmunomodulatory agent) and dexamethasone, or bortezomib (a PI) and dexamethasone.
About 9,500 veterans were removed from the Medicaid rolls under the Washington state initiative since the program began in 2003, saving the state $27 million, according to the National Coalition on Health Care. And now Oregon is taking baby steps toward imitating the success
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the type 2 diabetes drug market in Brazil will grow from $417 million in 2008 to $834 million in 2013.
Researchers from two universities have developed and tested a molecular platform that offers hope for treatment of aggressive brain tumors.
› Verified 6 days ago
Dr. Helen Mccarthy, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Pob1, Suite402, Chester, PA 19013 Phone: 610-447-6680 Fax: 610-447-6677 | |
Sarra Bae, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Blvd Ste 205, Chester, PA 19013 Phone: 610-619-7410 Fax: 610-876-8483 | |
Anjali Srivastava, M.D., M.B.A. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Crozer Pediatrics, Pob 1, Suite 205, Chester, PA 19013 Phone: 610-619-7410 Fax: 610-876-8483 | |
Shobhana Sathish, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Blvd, Pob1 Suite 402, Chester, PA 19013 Phone: 610-447-6680 Fax: 610-447-6677 | |
Mrs. Ashley Nicole Henderson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 30 Medical Center Boulevard, Suite #205, Chester, PA 19013 Phone: 610-619-7410 | |
Amber Christine Baisz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Blvd, Crozer Pediatrics, 1 Pob, Suite 205, Chester, PA 19013 Phone: 610-619-7410 Fax: 610-876-8483 | |
Salud Urtula Tiro, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 125 E 9th St, Chester, PA 19013 Phone: 610-872-6131 Fax: 610-872-5128 |